Equine CysC antibody and antigen (recombinant protein)

 Download 

Product information

Catalog No.	Description	US $ Price (per mg)
GMP-EQU-CysC-Ag01	Recombinant Equine CysC protein	3090
GMP-EQU-CysC-Ab01	Anti-Equine CysC mouse monoclonal antibody (mAb)	1953
GMP-EQU-CysC-Ab02	Anti-Equine CysC mouse monoclonal antibody (mAb)	1953
GMP-EQU-CysC-Ab03	Anti-Equine CysC human monoclonal antibody (mAb)	1953
GMP-EQU-CysC-Ab04	Anti-Equine CysC human monoclonal antibody (mAb)	1953

Size： 1mg | 10mg | 100mg

Product Description

Cat No. of Products	GMP-EQU-CysC-Ag01
Product Name	Recombinant Equine CysC protein
Target/Biomarker	Equine Cystatin C (CysC)
Expression platform	E.coli
Isotypes	Recombinant Antigen
Bioactivity validation	Anti-Equine Cystatin C antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CysC level test of animal Equine/Horse with Hormone disorders.
Tag	His
Products description	Recombinant Equine CysC protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-EQU-CysC-Ab01, GMP-EQU-CysC-Ab02
Product Name	Anti-Equine CysC mouse monoclonal antibody (mAb)
Target/Biomarker	Equine Cystatin C (CysC)
Expression platform	CHO
Isotypes	Mouse IgG
Bioactivity validation	Recombinant Equine Cystatin C antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-CysC antibodies in CysC level test of animal Equine/Horse with Hormone disorders.
Tag	mFc
Products description	Anti-Equine CysC mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-CysC antibodies.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-EQU-CysC-Ab03, GMP-EQU-CysC-Ab04
Product Name	Anti-Equine CysC human monoclonal antibody (mAb)
Target/Biomarker	Equine Cystatin C (CysC)
Expression platform	CHO
Isotypes	Human IgG1
Bioactivity validation	Recombinant Equine Cystatin C antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-CysC antibodies in CysC level test of animal Equine/Horse with Hormone disorders.
Tag	hFc
Products description	Anti-Equine CysC human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-CysC antibodies.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Target/Biomarker information

Equine CYSC, or Cystatin C, may appear modest in size, but its significance in the realm of equine health is monumental. This unassuming biomarker operates as a vigilant guardian, meticulously assessing the intricate machinery within a horse's body, specifically, the renal system. Produced by cells throughout a horse's body at a constant rate, Equine CYSC embarks on a journey that culminates in the evaluation of renal health. Its voyage begins within the glomeruli, the complex filtration units nestled within the horse's kidneys. Here, Equine CYSC is filtered from the blood, marking the initial step in the assessment of renal function. Following its passage through the glomeruli, Equine CYSC continues its odyssey through the renal tubules. Its fate is intricately tied to the efficiency of glomerular filtration. In healthy horses, the majority of CYSC is reabsorbed and subsequently catabolized by the tubules. This intricate process ensures that CYSC levels in the bloodstream remain relatively stable, mirroring the efficiency of glomerular filtration. The true strength of Equine CYSC lies in its sensitivity and specificity as a biomarker for renal health. Unlike traditional markers such as creatinine, which can be influenced by factors like muscle mass or diet, CYSC remains relatively immune to these variables. This precision makes CYSC an invaluable tool for the early detection of kidney disease in horses. Equine CYSC is not merely a biomarker; it is the herald of proactive healthcare. Its ability to detect subtle shifts in renal function, often before overt clinical symptoms manifest, makes it a powerful asset. Regular monitoring of CYSC levels can unveil renal issues in their infancy, allowing for timely intervention and an increased likelihood of successful treatment.

About GDU